ClinicalTrials.govpublic full text
Study to Evaluate Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and Older
herpes zoster, herpes zoster vaccine
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 195386
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.